Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Transmeta (TMTA)-The Monster That Could Slay Intel -- Ignore unavailable to you. Want to Upgrade?

To: William F. Wager, Jr. who wrote (217)	11/3/2000 2:09:57 PM
From: Neil H	Read Replies (1) \| Respond to of 421

Transmeta: IBM who? Company boosts its IPO price range despite Big Blue turnaround November 3, 2000: 1:06 p.m. ET NEW YORK (CNNfn) - Mobile computer chip company Transmeta Corp. sent a big message to the initial public offering market Friday -- watch out for Transmeta next week. Despite the black eye of IBM scrapping plans to use Transmeta's Crusoe microprocessor in an upcoming notebook, Transmeta boosted its expected IPO pricing range $5, nearly 50 percent, to between $16 and $18. "This shows a tremendous amount of confidence," said Ben Holmes, president of IPOPros.com. "That's saying: 'We've got (share) orders, buddy.' I wouldn't be surprised if we saw an increase in shares." The company now plans to raise about $221 million by selling 13 million shares, up from original expectations of $156 million. According to lead underwriter Morgan Stanley Dean Witter, the stock will price Monday, Nov. 6.